Engineering algae to make complex anti-cancer 'designer' drug
Biologists at UC San Diego have succeeded in genetically engineering algae to produce a complex and expensive human therapeutic drug used to treat cancer.
Biologists at UC San Diego have succeeded in genetically engineering algae to produce a complex and expensive human therapeutic drug used to treat cancer.
Cell & Microbiology
Dec 10, 2012
1
0
Based on two new studies by researchers at the Salk Institute for Biological Studies, regeneration of a new limb or organ in a human will be much more difficult than the mad scientist and supervillain, Dr. Curt Connors, made ...
Biotechnology
Sep 25, 2012
1
0
(Phys.org)—Highly sensitive and highly selective tests are important for the early detection of disease, the detection of environmental toxins, or for the detection of explosives at airports. Increased selectivity for the ...
Materials Science
Aug 27, 2012
1
0
Stem cell scientists at King's College London will today announce they have submitted to the UK Stem Cell Bank (UKSCB) their first clinical grade human embryonic stem (hES) cell lines that are free from animal-derived products, ...
Cell & Microbiology
Dec 6, 2011
0
0
In a new study, Chen-Yu Zhang's group at Nanjing university present a rather striking finding that plant miRNAs could make into the host blood and tissues via the route of food-intake. Moreover, once inside the host, they ...
Cell & Microbiology
Sep 19, 2011
4
0
The days of the blood sample routine - arm out, tie tube, make a fist, find a vein and tap in -- may soon be over, thanks to a new analysis method developed at U of T by Institute of Biomaterials and Biomedical Engineering ...
Analytical Chemistry
Aug 31, 2011
0
0
Indiana University scientists have found chemical flame retardants in the blood of pet dogs at concentrations five to 10 times higher than in humans, but lower than levels found in a previous study of cats.
Environment
Apr 26, 2011
0
0
(PhysOrg.com) -- In what can only be described as cosmic forces at work, Japanese scientists working at Yokohama University, just south of Tokyo, have in the midst of a national crises, announced a major breakthrough in fertility ...
Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic and inflammatory diseases, announced today the publication of collaborative research in the International Journal of Biochemistry ...
Biotechnology
Feb 10, 2011
0
0
Searching for a needle in a haystack may seem futile, but it's worth it if the needle is a hard-to-detect protein that may identify a person at high risk of a heart attack circulating within a haystack of human serum (liquid ...
Analytical Chemistry
Nov 4, 2009
0
0